SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro

SARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis and increased pulmonary vascular permeability leading to edema and hemorrhage. In addition to the lung, cytokine storm-induced inflammatory cascade also affects other organs. SARS-CoV-2 infection-related vascular...

Full description

Bibliographic Details
Main Authors: Fengming Liu, Kun Han, Robert Blair, Kornelia Kenst, Zhongnan Qin, Berin Upcin, Philipp Wörsdörfer, Cecily C. Midkiff, Joseph Mudd, Elizaveta Belyaeva, Nicholas S. Milligan, Tyler D. Rorison, Nicole Wagner, Jochen Bodem, Lars Dölken, Bertal H. Aktas, Richard S. Vander Heide, Xiao-Ming Yin, Jay K. Kolls, Chad J. Roy, Jay Rappaport, Süleyman Ergün, Xuebin Qin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.701278/full
id doaj-e2de576c347c428db861b40e4ee8c99f
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Fengming Liu
Fengming Liu
Kun Han
Robert Blair
Kornelia Kenst
Zhongnan Qin
Berin Upcin
Philipp Wörsdörfer
Cecily C. Midkiff
Joseph Mudd
Elizaveta Belyaeva
Nicholas S. Milligan
Tyler D. Rorison
Nicole Wagner
Jochen Bodem
Lars Dölken
Bertal H. Aktas
Richard S. Vander Heide
Xiao-Ming Yin
Jay K. Kolls
Chad J. Roy
Chad J. Roy
Jay Rappaport
Jay Rappaport
Süleyman Ergün
Xuebin Qin
Xuebin Qin
spellingShingle Fengming Liu
Fengming Liu
Kun Han
Robert Blair
Kornelia Kenst
Zhongnan Qin
Berin Upcin
Philipp Wörsdörfer
Cecily C. Midkiff
Joseph Mudd
Elizaveta Belyaeva
Nicholas S. Milligan
Tyler D. Rorison
Nicole Wagner
Jochen Bodem
Lars Dölken
Bertal H. Aktas
Richard S. Vander Heide
Xiao-Ming Yin
Jay K. Kolls
Chad J. Roy
Chad J. Roy
Jay Rappaport
Jay Rappaport
Süleyman Ergün
Xuebin Qin
Xuebin Qin
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
Frontiers in Cellular and Infection Microbiology
endothelial cell infection
animal models
SARS-CoV-2
aorta ring
hACE2
author_facet Fengming Liu
Fengming Liu
Kun Han
Robert Blair
Kornelia Kenst
Zhongnan Qin
Berin Upcin
Philipp Wörsdörfer
Cecily C. Midkiff
Joseph Mudd
Elizaveta Belyaeva
Nicholas S. Milligan
Tyler D. Rorison
Nicole Wagner
Jochen Bodem
Lars Dölken
Bertal H. Aktas
Richard S. Vander Heide
Xiao-Ming Yin
Jay K. Kolls
Chad J. Roy
Chad J. Roy
Jay Rappaport
Jay Rappaport
Süleyman Ergün
Xuebin Qin
Xuebin Qin
author_sort Fengming Liu
title SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
title_short SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
title_full SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
title_fullStr SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
title_full_unstemmed SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
title_sort sars-cov-2 infects endothelial cells in vivo and in vitro
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2021-07-01
description SARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis and increased pulmonary vascular permeability leading to edema and hemorrhage. In addition to the lung, cytokine storm-induced inflammatory cascade also affects other organs. SARS-CoV-2 infection-related vascular inflammation is characterized by endotheliopathy in the lung and other organs. Whether SARS-CoV-2 causes endotheliopathy by directly infecting endothelial cells is not known and is the focus of the present study. We observed 1) the co-localization of SARS-CoV-2 with the endothelial cell marker CD31 in the lungs of SARS-CoV-2-infected mice expressing hACE2 in the lung by intranasal delivery of adenovirus 5-hACE2 (Ad5-hACE2 mice) and non-human primates at both the protein and RNA levels, and 2) SARS-CoV-2 proteins in endothelial cells by immunogold labeling and electron microscopic analysis. We also detected the co-localization of SARS-CoV-2 with CD31 in autopsied lung tissue obtained from patients who died from severe COVID-19. Comparative analysis of RNA sequencing data of the lungs of infected Ad5-hACE2 and Ad5-empty (control) mice revealed upregulated KRAS signaling pathway, a well-known pathway for cellular activation and dysfunction. Further, we showed that SARS-CoV-2 directly infects mature mouse aortic endothelial cells (AoECs) that were activated by performing an aortic sprouting assay prior to exposure to SARS-CoV-2. This was demonstrated by co-localization of SARS-CoV-2 and CD34 by immunostaining and detection of viral particles in electron microscopic studies. Moreover, the activated AoECs became positive for ACE-2 but not quiescent AoECs. Together, our results indicate that in addition to pneumocytes, SARS-CoV-2 also directly infects mature vascular endothelial cells in vivo and ex vivo, which may contribute to cardiovascular complications in SARS-CoV-2 infection, including multipleorgan failure.
topic endothelial cell infection
animal models
SARS-CoV-2
aorta ring
hACE2
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.701278/full
work_keys_str_mv AT fengmingliu sarscov2infectsendothelialcellsinvivoandinvitro
AT fengmingliu sarscov2infectsendothelialcellsinvivoandinvitro
AT kunhan sarscov2infectsendothelialcellsinvivoandinvitro
AT robertblair sarscov2infectsendothelialcellsinvivoandinvitro
AT korneliakenst sarscov2infectsendothelialcellsinvivoandinvitro
AT zhongnanqin sarscov2infectsendothelialcellsinvivoandinvitro
AT berinupcin sarscov2infectsendothelialcellsinvivoandinvitro
AT philippworsdorfer sarscov2infectsendothelialcellsinvivoandinvitro
AT cecilycmidkiff sarscov2infectsendothelialcellsinvivoandinvitro
AT josephmudd sarscov2infectsendothelialcellsinvivoandinvitro
AT elizavetabelyaeva sarscov2infectsendothelialcellsinvivoandinvitro
AT nicholassmilligan sarscov2infectsendothelialcellsinvivoandinvitro
AT tylerdrorison sarscov2infectsendothelialcellsinvivoandinvitro
AT nicolewagner sarscov2infectsendothelialcellsinvivoandinvitro
AT jochenbodem sarscov2infectsendothelialcellsinvivoandinvitro
AT larsdolken sarscov2infectsendothelialcellsinvivoandinvitro
AT bertalhaktas sarscov2infectsendothelialcellsinvivoandinvitro
AT richardsvanderheide sarscov2infectsendothelialcellsinvivoandinvitro
AT xiaomingyin sarscov2infectsendothelialcellsinvivoandinvitro
AT jaykkolls sarscov2infectsendothelialcellsinvivoandinvitro
AT chadjroy sarscov2infectsendothelialcellsinvivoandinvitro
AT chadjroy sarscov2infectsendothelialcellsinvivoandinvitro
AT jayrappaport sarscov2infectsendothelialcellsinvivoandinvitro
AT jayrappaport sarscov2infectsendothelialcellsinvivoandinvitro
AT suleymanergun sarscov2infectsendothelialcellsinvivoandinvitro
AT xuebinqin sarscov2infectsendothelialcellsinvivoandinvitro
AT xuebinqin sarscov2infectsendothelialcellsinvivoandinvitro
_version_ 1721317254189023232
spelling doaj-e2de576c347c428db861b40e4ee8c99f2021-07-06T14:30:57ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-07-011110.3389/fcimb.2021.701278701278SARS-CoV-2 Infects Endothelial Cells In Vivo and In VitroFengming Liu0Fengming Liu1Kun Han2Robert Blair3Kornelia Kenst4Zhongnan Qin5Berin Upcin6Philipp Wörsdörfer7Cecily C. Midkiff8Joseph Mudd9Elizaveta Belyaeva10Nicholas S. Milligan11Tyler D. Rorison12Nicole Wagner13Jochen Bodem14Lars Dölken15Bertal H. Aktas16Richard S. Vander Heide17Xiao-Ming Yin18Jay K. Kolls19Chad J. Roy20Chad J. Roy21Jay Rappaport22Jay Rappaport23Süleyman Ergün24Xuebin Qin25Xuebin Qin26Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United StatesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United StatesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United StatesInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyInstitute of Virology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyInstitute of Virology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyDivision of Hematology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United StatesDepartment of Pathology, LSU Health Sciences Center, New Orleans, LA, United StatesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United StatesDepartments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, United StatesInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, United StatesSARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis and increased pulmonary vascular permeability leading to edema and hemorrhage. In addition to the lung, cytokine storm-induced inflammatory cascade also affects other organs. SARS-CoV-2 infection-related vascular inflammation is characterized by endotheliopathy in the lung and other organs. Whether SARS-CoV-2 causes endotheliopathy by directly infecting endothelial cells is not known and is the focus of the present study. We observed 1) the co-localization of SARS-CoV-2 with the endothelial cell marker CD31 in the lungs of SARS-CoV-2-infected mice expressing hACE2 in the lung by intranasal delivery of adenovirus 5-hACE2 (Ad5-hACE2 mice) and non-human primates at both the protein and RNA levels, and 2) SARS-CoV-2 proteins in endothelial cells by immunogold labeling and electron microscopic analysis. We also detected the co-localization of SARS-CoV-2 with CD31 in autopsied lung tissue obtained from patients who died from severe COVID-19. Comparative analysis of RNA sequencing data of the lungs of infected Ad5-hACE2 and Ad5-empty (control) mice revealed upregulated KRAS signaling pathway, a well-known pathway for cellular activation and dysfunction. Further, we showed that SARS-CoV-2 directly infects mature mouse aortic endothelial cells (AoECs) that were activated by performing an aortic sprouting assay prior to exposure to SARS-CoV-2. This was demonstrated by co-localization of SARS-CoV-2 and CD34 by immunostaining and detection of viral particles in electron microscopic studies. Moreover, the activated AoECs became positive for ACE-2 but not quiescent AoECs. Together, our results indicate that in addition to pneumocytes, SARS-CoV-2 also directly infects mature vascular endothelial cells in vivo and ex vivo, which may contribute to cardiovascular complications in SARS-CoV-2 infection, including multipleorgan failure.https://www.frontiersin.org/articles/10.3389/fcimb.2021.701278/fullendothelial cell infectionanimal modelsSARS-CoV-2aorta ringhACE2